Home » Newsletters » BioWorld Science

BioWorld Science

May 10, 1999

View Archived Issues

Amarillo's fibromyalgia trial expanded

Natural insulin-sensitizing agent may help cure PCOS infertility

Oxigene: Annual Report 1998/Q1 1999 highlights

Company Profile: Nanosyn

Sublingual apomorphine aids in erectile dysfunction

Lilly: Annual Report 1998

Neurocrine Biosciences: Q1 1999 highlights

Yamanouchi describes novel series of factor Xa inhibitors

IND exemption granted to Polydex's STD/contraceptive drug

Potent, orally active antiulcer agents synthesized at SS Pharm.

Sankyo's new antibiotics described in patent literature

New antiinflammatory/analgesic agents with both topical and oral activity

Telmisartan now available in Spanish pharmacies

Naturally occurring terpene with immunosuppressive and neovascularization-inhibitory effects

NA-00226B and C, produced by Streptomyces, inhibit cAMP PDE activity

Licensing opportunity from NIH: recombinant antitumor RNases

HCV antisense oligonucleotide reduces HCV gene expression in mouse model

Progenics: Q1 1999 highlights

Licensing opportunity from NIH: BChE inhibitors for Alzheimer's disease Rx, Dx

Phase I trial results reported for GA-EPO at nephrology congress

AVI BioPharma: Q1 1999 highlights

KH-1060: immunomodulating effects studied in mouse skin graft model

LU-135252 used to investigate role of ETA receptor in cardiac hypertrophy

Beneficial effects of TAK-044 in kidney autotransplanted dogs

PST-2238: novel antihypertensive agent targeting ouabain

Structural Bioinformatics develops antagonists of BcL-2 gene product

Flixotide submitted for COPD in major markets

Single-isomer valproic acid patented in Japan

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...